Subscribe to RSS
DOI: 10.1055/a-2465-5163
Omega-3 Levels in Prenatal Supplements
Funding None.
Abstract
Objective This study aimed to systematically document the reported omega-3 levels in commercially available prenatal supplements in the United States and Canada, and compare these levels to recommended intakes in pregnancy.
Study Design Commercial prenatal supplements were identified using the Dietary Supplement Label Database (n = 50) and the Licensed Natural Health Products Database (n = 18). Mean omega-3 levels and the proportion of products meeting recommendations for pregnant women were tabulated.
Results Average omega-3 levels were 368 ± 33 mg in the United States and 404 ± 72 mg in Canada. Seventy percent of products in the United States and 61% in Canada contained the amount of omega-3 levels recommended for pregnant women with sufficient intakes. Sixteen percent of products in the United States and 28% in Canada contained the dose recommended for pregnant women with insufficient intakes.
Conclusion These results illustrate that commercial prenatal supplements contain a wide variety of omega-3 fatty acid levels that may or may not be consistent with recommended intake levels.
Key Points
-
most pregnant women consume inadequate amounts of omega-3 fatty acids.
-
omega-3 fatty acids can help prevent preterm birth.
-
new guidelines recommend increased intakes of omega-3 fatty acids during pregnancy.
-
prenatal supplements contain a wide variety of omega-3 fatty acid levels.
-
omega-3 levels in prenatal supplements may or may not be consistent with recommended intake levels.
Authors' Contributions
M.J.S. takes responsibility for the integrity of the data and the accuracy of the data analysis.
M.J.S. conceived the study. M.J.S., E.H.H., M.T.K., L.R., and M.F. designed the study. M.J.S. and Harper acquired the data. M.J.S. analyzed and interpreted the data and wrote the manuscript. M.J.S., E.H.H., M.T.K., L.R., and M.F. reviewed the manuscript for important intellectual content and approved the final version. M.F. and M.T.K. supervised the study.
Publication History
Received: 09 July 2024
Accepted: 11 November 2024
Article published online:
04 December 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Zhang Z, Fulgoni VL, Kris-Etherton PM, Mitmesser SH. Dietary intakes of EPA and DHA Omega-3 fatty acids among us childbearing-age and pregnant women: an analysis of NHANES 2001-2014. Nutrients 2018; 10 (04) 10
- 2 Denomme J, Stark KD, Holub BJ. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr 2005; 135 (02) 206-211
- 3 Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018; 11 (11) CD003402
- 4 March of Dimesǀ . The Partnership ǀ Save the Children ǀ World Health Organization; Born Too Soon: The Global Action Report on Preterm Birth. 2012
- 5 Cetin I, Carlson SE, Burden C. et al; Clinical Practice Guideline on behalf of Asia Pacific Health Association (Pediatric-Neonatology Branch), Child Health Foundation (Stiftung Kindergesundheit), European Academy of Paediatrics, European Board & College of Obstetrics and Gynaecology, European Foundation for the Care of Newborn Infants, European Society for Paediatric Research, and International Society for Developmental Origins of Health and Disease. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth. Am J Obstet Gynecol MFM 2024; 6 (02) 101251
- 6 Bloomingdale A, Guthrie LB, Price S. et al. A qualitative study of fish consumption during pregnancy. Am J Clin Nutr 2010; 92 (05) 1234-1240
- 7 Adams JB, Kirby JK, Sorensen JC, Pollard EL, Audhya T. Evidence based recommendations for an optimal prenatal supplement for women in the US: vitamins and related nutrients. Matern Health Neonatol Perinatol 2022; 8 (01) 4
- 8 Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2019; 2019 (10) CD004659